GEVA : Insider Transactions for Synageva BioPharma Corp | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Synageva BioPharma Corp (GEVA)

$0.00 0.00 (0.00%) as of 4:30 Fri 2/14

Download

Exchange:

Nasdaq National Market

Security Type:

Common

Shares Out:

34,000,000

Market Cap:

N/A

Last Volume:

18,050

Avg Vol:

18,000

52 Week Range:

$238.6 - $238.6

Level I Sector:

Health Care

Level II Sector:

Drugs

Level III Sector:

Biotechnology

Member Indexes:

	NASDAQ BIOTECHNOLOGY		NASDAQ COMPOSITE
	NASDAQ NNM COMPOSITE

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -


Company Profile

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	0
Total Buy Value	$0	$0	$0	$0
Total People Bought	0	0	0	0
Total Buy Transactions	0	0	0	0
Total Shares Sold	0	0	0	0
Total Sell Value	$0	$0	$0	$0
Total People Sold	0	0	0	0
Total Sell Transactions	0	0	0	0
End Date	2024-01-28	2023-10-27	2023-04-28	2022-04-28

Adjust Filter Settings

Records found: 372

Page 5 of 15

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

SVP, Technical Operations

• – –

2013-12-31

4

A

$36.30

$4,792

D/D

132

266

-

Group Vice President, Finance

• – –

2013-12-31

4

A

$36.30

$6,970

D/D

192

192

-

Goldberg Mark Alan

EVP, Medical & Reg. Strategy

• – –

2013-12-31

4

A

$36.30

$6,970

D/D

192

459

-

Goldberg Mark Alan

SVP,Medical&Regulatory Affairs

• – –

2013-12-03

4

AS

$60.49

$423,649

D/D

(7,000)

267

-

Goldberg Mark Alan

SVP,Medical&Regulatory Affairs

• – –

2013-12-02

4

OE

$8.73

$61,110

D/D

7,000

7,267

-

SVP, Chief Financial Officer

• – –

2013-11-18

4

AS

$53.98

$546,857

D/D

(9,927)

0

-

SVP, Chief Financial Officer

• – –

2013-11-18

4

OE

$1.70

$16,876

D/D

9,927

9,927

-

Goldberg Mark Alan

SVP,Medical&Regulatory Affairs

• – –

2013-11-01

4

AS

$49.61

$349,753

D/D

(7,000)

267

-

Goldberg Mark Alan

SVP,Medical&Regulatory Affairs

• – –

2013-11-01

4

OE

$8.73

$61,110

D/D

7,000

7,267

-

Goldberg Mark Alan

SVP,Medical&Regulatory Affairs

• – –

2013-10-01

4

AS

$63.97

$450,203

D/D

(7,000)

267

-

Goldberg Mark Alan

SVP,Medical&Regulatory Affairs

• – –

2013-10-01

4

OE

$8.73

$61,110

D/D

7,000

7,267

-

Director

– • •

2013-09-25

4

B

$56.63

$59,461,500

I/I

1,050,000

202,583

2.25

-

Director

– • •

2013-09-25

4

B

$56.63

$59,461,500

I/I

1,050,000

202,583

2.25

-

SVP, Chief Financial Officer

• – –

2013-08-21

4

AS

$47.19

$315,276

D/D

(6,681)

0

-

SVP, Chief Financial Officer

• – –

2013-08-21

4

OE

$23.00

$153,663

D/D

6,681

6,681

-

SVP, Chief Financial Officer

• – –

2013-08-20

4

AS

$47.04

$366,912

D/D

(7,800)

0

-

SVP, Chief Financial Officer

• – –

2013-08-20

4

OE

$1.70

$59,545

D/D

7,800

7,800

-

SVP, Chief Financial Officer

• – –

2013-08-16

4

AS

$47.47

$204,121

D/D

(4,300)

0

-

SVP, Chief Financial Officer

• – –

2013-08-16

4

OE

$1.70

$7,310

D/D

4,300

4,300

-

President & CEO

• • –

2013-07-29

4

AS

$47.39

$753,264

D/D

(15,895)

1,031

-

President & CEO

• • –

2013-07-29

4

OE

$3.52

$55,950

D/D

15,895

16,926

-

President & CEO

• • –

2013-07-26

4

AS

$47.91

$3,331,548

D/D

(69,394)

1,031

-

President & CEO

• • –

2013-07-26

4

OE

$1.70

$152,984

D/D

52,190

70,425

-

President & CEO

• • –

2013-07-25

4

AS

$48.73

$716,867

D/D

(14,711)

18,235

-

President & CEO

• • –

2013-07-25

4

OE

$0.95

$45,319

D/D

31,915

32,946

-

372 Records found	1 2 3 4 5 6 7 8 9 Next	Page 5 of 15

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.